title: How do we operationalize the individualization of ESA dosing and target Hb levels?
authors.affiliation: Yale University, New Haven, CT, USA.
authors.forename: Fredric O
authors.initials: FO
authors.lastname: Finkelstein
mesh_terms: D000740:Anemia / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D016903:Drug Monitoring / Q000379:methods*; D004921:Erythropoietin / Q000008:administration & dosage*; D006397:Hematinics / Q000008:administration & dosage; D006454:Hemoglobins; D006801:Humans; D051436:Renal Insufficiency, Chronic / Q000097:blood / Q000150:complications*
chemical_list: D006397:Hematinics; D006454:Hemoglobins; D004921:Erythropoietin